FABP1 and diabetes mellitus: These findings suggested that L-FABP may function as an intracellular fatty acid synthesis inhibitor binding proteinfacilitating TOFA and C75-mediated induction of PPARα in the context of high glucose at levels similar to those in uncontrolled diabetes.